D-Wave Quantum’s $6.8 Billion Valuation Hinges on Turning Orders into Revenue

The math behind D-Wave Quantum’s stock price is becoming increasingly difficult to square with its financial statements. The quantum computing company closed last week at $18.52, down roughly 4% on Friday, as a consolidation phase that began after the shares briefly topped $22 continues to weigh on sentiment. The stock now trades about 34% below where it started the year and remains a long way from its 52-week high near $47.

A Technical Milestone That Failed to Move the Market

D-Wave recently achieved something genuinely significant: a peer-reviewed study confirmed that its Advantage2 prototype outperformed classical supercomputers in materials simulations. It is the kind of breakthrough that should have sent the stock soaring. Instead, the market barely blinked. The disconnect highlights just how much of D-Wave’s story is now priced in — and how much skepticism remains about the company’s ability to commercialize its technology.

The broader analyst community remains overwhelmingly bullish. Of the 17 analysts covering the stock, 14 rate it a buy. The average price target stands at $35.53, implying roughly 92% upside from current levels. One estimate places fair value even higher, at around $40.65. But those targets are looking increasingly aspirational as the stock struggles to hold its ground.

A Cash-Rich but Loss-Heavy Balance Sheet

D-Wave’s liquidity position is one of its few unambiguous strengths. As of February 2026, the company held more than $884 million in cash and marketable securities. That war chest provides ample runway, even as losses continue to mount. The company reported a net loss of $355.1 million on revenue of just $24.6 million for its most recent fiscal year.

The valuation math is stark. With a market capitalization of roughly $6.85 billion, D-Wave trades at a price-to-sales ratio well north of 300 times. That kind of multiple demands extraordinary growth — and soon.

The Order Book Versus the Income Statement

The fundamental tension in D-Wave’s story lies between its order book and its reported revenue. In January 2026 alone, the company booked more orders than it did in all of the previous year. Those orders include a $20 million system sale and a cloud contract with a major corporation. Yet the revenue line has yet to reflect that surge.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Investors will get their next look at the numbers on May 12, when D-Wave reports first-quarter 2026 results before the market opens. This will be the first report to fully include the acquisition of Quantum Circuits, which the company completed earlier this year. CEO Alan Baratz and CFO John Markovich are scheduled to hold a conference call at 8:00 a.m. Eastern time to discuss the results and provide strategic guidance for the remainder of the year.

Mixed Signals from Wall Street

Northland Securities initiated coverage on Monday with a Market Perform rating and a $22 price target. The analysts acknowledged D-Wave’s long-term potential in quantum computing but struck a more cautious tone compared to some peers. Mizuho, meanwhile, trimmed its price target to $31 while maintaining an Outperform rating, describing the sector as being at an early inflection point.

The consensus price target among analysts covering the stock sits at roughly $32, reflecting broad optimism — but also a wide range of views on how quickly D-Wave can translate its technological lead into sustainable revenue.

Government Backing and a Pivotal Quarter

D-Wave received a notable endorsement from the U.S. Defense Advanced Research Projects Agency in mid-April, when DARPA launched a new program focused on heterogeneous quantum architectures. The initiative aims to combine different qubit types within a single system — an approach that aligns directly with D-Wave’s strategy following its acquisition of Quantum Circuits, which brought two distinct quantum platforms under one roof.

The May 12 earnings report will be the first real test of whether that strategy is gaining commercial traction. The market will be watching closely to see how quickly the January order surge flows through to the income statement. If revenue remains elusive, the current valuation could come under severe pressure. If the numbers show meaningful progress, the stock may finally start closing the gap with its analyst targets.